Who invested in Maze Therapeutics?
Maze Therapeutics's investors include General Catalyst, ARCH Venture Partners, Janus Henderson Investors, TCG and TCG Crossover, and 1 more on record.

United States · Funded startup
Funding summaryUpdated 26 Oct 2026
$300Mraised across 2 rounds since 2025, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Source recorded
Source recorded
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Maze Therapeutics's investors include General Catalyst, ARCH Venture Partners, Janus Henderson Investors, TCG and TCG Crossover, and 1 more on record.
Maze Therapeutics has raised $300M across 2 rounds since 2025.
Maze Therapeutics's most recent round was an Undisclosed round of $150M in Apr 2026.
Its most recent round, $150M in Apr 2026, is also its largest on record.
Maze Therapeutics's first round on record, in Sept 2025, was backed by General Catalyst, ARCH Venture Partners and Janus Henderson Investors and 2 others.
Maze Therapeutics's latest named round is an Undisclosed round, in Apr 2026.
Maze Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.